Home › Research › Health systems and care delivery
Continued Use of Warfarin in Veterans with Atrial Fibrillation After Dementia Diagnosis
Ariela R. Orkaby, Al Ozonoff, Joel I. Reisman, Donald Ray Miller, Shibei Zhao, Adam J. Rose. Journal of the American Geriatrics Society, 2016-12-30
Topic: Risk, prevention and care in population studies
Plain-language summary
The average CHADS2 score was 3.3 ± 1.3. After a diagnosis of dementia, 405 individuals (16%) persisted on warfarin therapy. Unadjusted Cox proportional hazards analysis demonstrated a protective effect of warfarin in prevention of ischemic stroke (hazard ratio (HR) = 0.64, 95% confidence interval (CI) = 0.46-0.89, P = .008), major bleeding (HR = 0.72, 95% CI = 0.55-0.94, P = .02), and all-cause mortality (HR = 0.66, 95% CI = 0.55-0.79, P < .001). Using propensity score matching, the protective effect of continuing warfarin persisted in prevention of stroke (HR = 0.74, 95% CI = 0.54-0.996, P = .047) and mortality (HR = 0.72, 95% CI = 0.60-0.87, P < .001), with no statistically significant decrease in risk of major bleeding (HR = 0.78, 95% CI = 0.61-1.01, P = .06). Discontinuing warfarin after a diagnosis of dementia is associated with a significant increase in stroke and mortality.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 2,572 participants. This study found that continuing warfarin after a dementia diagnosis in veterans with atrial fibrillation was associated with lower risk of stroke and mortality. Reported effect size: HR = 0.72; HR = 0.66; HR = 0.74.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Orkaby, A. R., Ozonoff, A., Reisman, J. I., Miller, D. R., Zhao, S., & Rose, A. J. (2016). Continued Use of Warfarin in Veterans with Atrial Fibrillation After Dementia Diagnosis. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.14573
Vancouver
Orkaby AR, Ozonoff A, Reisman JI, Miller DR, Zhao S, Rose AJ. Continued Use of Warfarin in Veterans with Atrial Fibrillation After Dementia Diagnosis. Journal of the American Geriatrics Society. 2016. doi:10.1111/jgs.14573. PMID: 28039854.
BibTeX
@article{orkaby2016-28039854,
author = {Orkaby, Ariela R. and Ozonoff, Al and Reisman, Joel I. and Miller, Donald Ray and Zhao, Shibei and Rose, Adam J.},
title = {{Continued Use of Warfarin in Veterans with Atrial Fibrillation After Dementia Diagnosis}},
journal = {Journal of the American Geriatrics Society},
year = {2016},
doi = {10.1111/jgs.14573},
pmid = {28039854},
url = {https://doi.org/10.1111/jgs.14573}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- After a diagnosis of dementia, 405 individuals (16%) persisted on warfarin therapy.
- Unadjusted Cox proportional hazards analysis demonstrated a protective effect of warfarin in prevention of ischemic stroke (hazard ratio (HR) = 0.64, 95% confidence interval (CI) = 0.46-0.89, P = .008), major bleeding (HR = 0.72, 95% CI = 0.55-0.94, P = .02), and all-cause mortality (HR = 0.66, 95% CI = 0.55-0.79, P < .001).
- Using propensity score matching, the protective effect of continuing warfarin persisted in prevention of stroke (HR = 0.74, 95% CI = 0.54-0.996, P = .047) and mortality (HR = 0.72, 95% CI = 0.60-0.87, P < .001), with no statistically significant decrease in risk of major bleeding (HR = 0.78, 95% CI = 0.61-1.01, P = .06).
- Discontinuing warfarin after a diagnosis of dementia is associated with a significant increase in stroke and mortality.
Why it matters
This study found that continuing warfarin after a dementia diagnosis in veterans with atrial fibrillation was associated with lower risk of stroke and mortality. It does not test any treatment, cure, or prevention for Alzheimer's disease, and it suggests discontinuing warfarin after dementia diagnosis is associated with increased stroke and mortality.
Study details
- Study designcohort study
- Participants2,572
- Effect sizeHR = 0.72; HR = 0.66; HR = 0.74
- Evidence strengthModerate
How this study scored 59/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the American Geriatrics Society) |
| Journal's citation record | 3 / 4 | Journal of the American Geriatrics Society: journal h-index 344 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2016 — within 20 year(s) of the newest study here |
| Sample size | 3 / 4 | 2,572 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 42 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.5 citations a year over 12 year(s) since 2016 |
| Impact for its field and year | 3 / 6 | Cited 5.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Adam J. Rose: h-index 40 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 28039854) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 59 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Health systems and care delivery from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.